Scientific deep-dive
Where to Inject a GLP-1, and Why Rotation Matters
Abdomen, front of thigh, or back of the upper arm — subcutaneous, never muscle. The instruction people skip is rotation, and skipping it can look exactly like the drug failing.
Three places, and only three. Your abdomen, keeping clear of the navel by a couple of inches. Your thigh, on the front rather than the inner or outer side. Or the upper arm, around the back over the triceps. The needle goes into the fat layer just beneath the skin — subcutaneous — and never into muscle or a vein. Rotate with every dose. That last instruction is the one people skip, and it is the one with consequences.
This is the same guidance across every approved GLP-1: Wegovy, Ozempic, Zepbound, Mounjaro, Saxenda, Victoza and Trulicity all direct the same three sites.[1] Compounded preparations are injected the same way, though they arrive as a vial and a syringe rather than a pen, which adds a step and a measurement.
The three sites, and how to pick
| Site | Where exactly | Notes |
|---|---|---|
| Abdomen | Anywhere on the stomach at least 2 inches from the navel | The most commonly used site. Easiest to reach and to see, and there is usually plenty of subcutaneous fat. |
| Thigh | The front of the upper leg, mid-way between hip and knee | Easy to self-administer sitting down. Use the front, not the inner or outer thigh. |
| Upper arm | The back of the arm, over the triceps | Often the hardest to self-inject well; simpler if someone else is doing it. |
There is no evidence that one site works better than another for these drugs, and the label explicitly allows changing both the site and the time of day without altering the dose.[1] Pick what you can reach comfortably and reliably.
Why rotation matters more than the site
Injecting the same spot week after week causes lipohypertrophy: the fat under the skin thickens and scars into a firm, sometimes visibly raised patch. It is common, it is painless, and that is precisely the problem — people carry on injecting into it because it does not hurt.
Scarred tissue absorbs erratically. The same dose delivered into a lipohypertrophic site reaches the bloodstream unpredictably, so appetite suppression turns inconsistent and progress stalls without the drug or the dose being at fault. ⚠ The way this usually presents is as a plateau — and a plateau is the moment sellers pitch a dose increase or an upgraded tier. Paying more to solve an injection-technique problem is a bad trade, and it is a common one.
- Move at least two inches from your last injection, every time.
- Cycle across regions, not just within one. A workable pattern is abdomen, thigh, upper arm across roughly eight weeks, moving to a fresh spot within each region each time.
- Feel before you inject. Run your fingers over the site. Anything firm, lumpy or raised gets skipped until it resolves, which can take months of leaving it alone.
- Keep a record. Weekly dosing is easy to lose track of. Our rotation calendar exists for this, and a note on your phone works as well.
Vials and pens are not the same job
An approved product comes in a pen that dials a dose in milligrams. Most compounded GLP-1s come in a vial you draw from with an insulin syringe, which moves a measurement step from a factory to your kitchen table.
That is where the errors happen. FDA has documented patients receiving five to twenty times their intended dose from compounded semaglutide, largely because a vial is labeled in milligrams while a syringe is marked in units, and the number that converts one to the other depends on the concentration your pharmacy chose.[2] If you are drawing from a vial, our units-to-milligrams guide is the arithmetic you need before the injection technique matters at all.
The rest of the technique, briefly
- Room temperature stings less. Taking the pen or vial out of the fridge 15–30 minutes beforehand is the single easiest comfort improvement.
- Clean the site and let it dry. Injecting through wet alcohol is what makes it burn.
- Pinch or not, depending on your build. With a short needle and adequate subcutaneous fat, a pinch is often unnecessary. Ask whoever prescribed it what applies to you.
- Hold for the count the pen tells you. Pulling out early leaves part of the dose on your skin, and you will not reliably notice.
- Dispose in a sharps container. Not the bin. Pharmacies generally take them, and most states have a disposal program.
Common questions
Frequently Asked Questions
References
- 1.U.S. National Library of Medicine WEGOVY (semaglutide) injection — prescribing information, Section 2 Dosage and Administration DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
- 2.U.S. Food and Drug Administration FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products FDA Human Drug Compounding. 2024. https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
- 3.U.S. National Library of Medicine ZEPBOUND (tirzepatide) injection — prescribing information DailyMed. 2026. https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=ZEPBOUND
Related research
How Many Units Is Your GLP-1 Dose? It Depends on the Vial
A syringe measures volume, a dose is measured in milligrams, and the number connecting them is set by whichever pharmacy filled your vial. Full conversion tables for compounded semaglutide and tirzepatide.
8 min read
Do GLP-1 Patches Work? The Molecule Is Too Big
Skin stops molecules above roughly 500 daltons. Semaglutide weighs 4,114 and tirzepatide 4,813. No adhesive patch changes that, and no GLP-1 patch is FDA-approved.
7 min read
GLP-1 Eye Risks: Diabetic Retinopathy and NAION Are Not the Same Thing
Two distinct eye questions get merged into one headline. Diabetic retinopathy complications are on the semaglutide label and trace to blood sugar falling fast; NAION is a separate optic-nerve signal that Europe labeled in June 2025 and US labeling still does not mention.
12 min read
GLP-1 Hair Loss and Muscle Loss: What Was Measured
Hair shedding and lean-mass loss both appear in the trial record, and both are mostly consequences of losing weight quickly rather than of the drug. That is reassuring about mechanism and not reassuring about outcome, and this holds both.
11 min read
GLP-1 Pancreatitis and Gallbladder Risk: What the Labels Counted
Two labeled warnings that are not the same kind of problem. Gallbladder disease tracks with rapid weight loss and is well counted; pancreatitis is rarer, was an exclusion criterion in the pivotal trials, and the database studies disagree.
12 min read
GLP-1 Thyroid Cancer Risk: What the Boxed Warning Actually Says
Every semaglutide and tirzepatide label carries a boxed warning about thyroid C-cell tumors. It comes from rodent studies, the labels themselves say the human relevance is undetermined, and the human research published since does not agree with itself.
11 min read
Where to get tirzepatide (Mounjaro / Zepbound) online, safely: sellers our editors have checked
These are telehealth sellers our editors have checked. For each one we hold a price, the form the drug comes in, and the states it reaches.
No insurance needed · vetted by our editors
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Telos Rx
Starting below a standard dose, with microdose tiers
From $139/mo
Get started →Gala
Moving between compounded and brand without changing seller
From $149/mo
Get started →Synergy Rx
Knowing which pharmacy fills the vial — it names Belmar Pharmacy
From $349/mo
Get started →